Description
URINALYSIS COST PER TEST
First action · last action
2019-10-01 · 2021-01-12
Transactions
2
First transaction's obligation
$79,632
Base + all options value (sum of deltas)
$80,314
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$79,632= $79,632
- Mod P000012021-01-12+$682= $80,314
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$79,632 | $79,632 | URINALYSIS COST PER TEST |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-01-12 | +$682 | $80,314 | URINALYSIS COST PER TEST |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under Q515 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24523P0983 | CLINISYS, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $88,800 | FY2023 |
| 36C24523P0585 | FRIENDS MEDICAL LABORATORY, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $10,399 | FY2023 |
| 36C24523N0041 | AMERICAN NATIONAL RED CROSS, THE | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $93,245 | FY2023 |
| 36C24522N0018 | AMERICAN NATIONAL RED CROSS, THE | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $85,854 | FY2022 |
| 36C24521F0298 | SPECTRUM SERVICES GROUP INC | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $966,622 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24520P0017_3600_-NONE-_-NONE- · retrieved 2026-09-26.